Cargando…

Validation of the Asia-Pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in Chinese population

BACKGROUND: Colorectal cancer is one of the most common cancers in the world. Several studies suggest using the Asia-Pacific colorectal screening (APCS) score and its modified versions to select high-risk populations for early colonoscopy, but external validation remains rare, and which score should...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Yunxin, Zhuo, Lin, Dong, Dong, Zhuo, Lang, Lou, Peian, Cai, Ting, Chen, Siting, Pan, Jianqiang, Gao, Yihuan, Lu, Hang, Ma, Yue, Dong, Zongmei, Luo, Xiaohu, Zhao, Hongying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450334/
https://www.ncbi.nlm.nih.gov/pubmed/36071414
http://dx.doi.org/10.1186/s12885-022-10047-y
_version_ 1784784501487960064
author Kong, Yunxin
Zhuo, Lin
Dong, Dong
Zhuo, Lang
Lou, Peian
Cai, Ting
Chen, Siting
Pan, Jianqiang
Gao, Yihuan
Lu, Hang
Ma, Yue
Dong, Zongmei
Luo, Xiaohu
Zhao, Hongying
author_facet Kong, Yunxin
Zhuo, Lin
Dong, Dong
Zhuo, Lang
Lou, Peian
Cai, Ting
Chen, Siting
Pan, Jianqiang
Gao, Yihuan
Lu, Hang
Ma, Yue
Dong, Zongmei
Luo, Xiaohu
Zhao, Hongying
author_sort Kong, Yunxin
collection PubMed
description BACKGROUND: Colorectal cancer is one of the most common cancers in the world. Several studies suggest using the Asia-Pacific colorectal screening (APCS) score and its modified versions to select high-risk populations for early colonoscopy, but external validation remains rare, and which score should be selected for CRC screening in China is unclear. Validation of multiple scores in the same population might help to choose the best performing score. METHODS: We conducted a cross-sectional study under the framework of Cancer Screening Program in Urban China, data from asymptomatic colorectal cancer screening in Xuzhou was used to validate the APCS score, the colorectal neoplasia predict (CNP) score, the Korean colorectal screening (KCS) score, the Modified APCS score and the 8-point risk score in predicting colorectal advanced neoplasia (CAN). RESULTS: 1804 subjects were included in the analysis and 112 CAN (6.21%) was detected. In each score, the detection rate of CAN was higher in the high-risk group than in the non-high-risk group (P < 0.05), and the RR (95%C.I.) ranged 2.20 (1.50–3.22) [8-point risk] to 4.00 (2.41–6.65) [Modified APCS]. The c-statistics (95%C.I.) of the scoring systems ranged from 0.58 (0.53–0.62) [8-point risk] to 0.65 (0.61–0.69) [KCS]. The sensitivity (95%C.I.) of these systems ranged from 31.25 (22.83–40.70) [8-point risk] to 84.82 (76.81–90.90) [Modified APCS], while the specificity (95%C.I.) ranged from 43.50 (41.12–45.90) [Modified APCS] to 83.81 (81.96–85.53) [8-point risk]. Using the APCS scoring system as a comparator, the net reclassification improvement (NRI) of each modified version ranged from − 10.34% (95%C.I.: − 22.63 to 1.95%) [8-point risk] to 4.79% (95%C.I.: − 1.50% to 11.08) [KCS]. The colonoscopy resource load (95%C.I.) ranged from 9 [1–3] [8-point risk] to 11 [3–5] [APCS and Modified APCS]. CONCLUSIONS: The APCS score and its modified versions have certain ability to predict the risk of advanced neoplasia and reduce the resource load. The modified APCS score and the KCS score seemed the preferable systems to classify high risk subjects based on its high RR, sensitivity and predictive ability in the selected population. Future research could focus on adding risk factors or combining with laboratory test results to improve the predictive power of the scoring system.
format Online
Article
Text
id pubmed-9450334
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94503342022-09-08 Validation of the Asia-Pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in Chinese population Kong, Yunxin Zhuo, Lin Dong, Dong Zhuo, Lang Lou, Peian Cai, Ting Chen, Siting Pan, Jianqiang Gao, Yihuan Lu, Hang Ma, Yue Dong, Zongmei Luo, Xiaohu Zhao, Hongying BMC Cancer Research BACKGROUND: Colorectal cancer is one of the most common cancers in the world. Several studies suggest using the Asia-Pacific colorectal screening (APCS) score and its modified versions to select high-risk populations for early colonoscopy, but external validation remains rare, and which score should be selected for CRC screening in China is unclear. Validation of multiple scores in the same population might help to choose the best performing score. METHODS: We conducted a cross-sectional study under the framework of Cancer Screening Program in Urban China, data from asymptomatic colorectal cancer screening in Xuzhou was used to validate the APCS score, the colorectal neoplasia predict (CNP) score, the Korean colorectal screening (KCS) score, the Modified APCS score and the 8-point risk score in predicting colorectal advanced neoplasia (CAN). RESULTS: 1804 subjects were included in the analysis and 112 CAN (6.21%) was detected. In each score, the detection rate of CAN was higher in the high-risk group than in the non-high-risk group (P < 0.05), and the RR (95%C.I.) ranged 2.20 (1.50–3.22) [8-point risk] to 4.00 (2.41–6.65) [Modified APCS]. The c-statistics (95%C.I.) of the scoring systems ranged from 0.58 (0.53–0.62) [8-point risk] to 0.65 (0.61–0.69) [KCS]. The sensitivity (95%C.I.) of these systems ranged from 31.25 (22.83–40.70) [8-point risk] to 84.82 (76.81–90.90) [Modified APCS], while the specificity (95%C.I.) ranged from 43.50 (41.12–45.90) [Modified APCS] to 83.81 (81.96–85.53) [8-point risk]. Using the APCS scoring system as a comparator, the net reclassification improvement (NRI) of each modified version ranged from − 10.34% (95%C.I.: − 22.63 to 1.95%) [8-point risk] to 4.79% (95%C.I.: − 1.50% to 11.08) [KCS]. The colonoscopy resource load (95%C.I.) ranged from 9 [1–3] [8-point risk] to 11 [3–5] [APCS and Modified APCS]. CONCLUSIONS: The APCS score and its modified versions have certain ability to predict the risk of advanced neoplasia and reduce the resource load. The modified APCS score and the KCS score seemed the preferable systems to classify high risk subjects based on its high RR, sensitivity and predictive ability in the selected population. Future research could focus on adding risk factors or combining with laboratory test results to improve the predictive power of the scoring system. BioMed Central 2022-09-07 /pmc/articles/PMC9450334/ /pubmed/36071414 http://dx.doi.org/10.1186/s12885-022-10047-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kong, Yunxin
Zhuo, Lin
Dong, Dong
Zhuo, Lang
Lou, Peian
Cai, Ting
Chen, Siting
Pan, Jianqiang
Gao, Yihuan
Lu, Hang
Ma, Yue
Dong, Zongmei
Luo, Xiaohu
Zhao, Hongying
Validation of the Asia-Pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in Chinese population
title Validation of the Asia-Pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in Chinese population
title_full Validation of the Asia-Pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in Chinese population
title_fullStr Validation of the Asia-Pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in Chinese population
title_full_unstemmed Validation of the Asia-Pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in Chinese population
title_short Validation of the Asia-Pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in Chinese population
title_sort validation of the asia-pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in chinese population
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450334/
https://www.ncbi.nlm.nih.gov/pubmed/36071414
http://dx.doi.org/10.1186/s12885-022-10047-y
work_keys_str_mv AT kongyunxin validationoftheasiapacificcolorectalscreeningscoreanditsmodifiedversionsinpredictingcolorectaladvancedneoplasiainchinesepopulation
AT zhuolin validationoftheasiapacificcolorectalscreeningscoreanditsmodifiedversionsinpredictingcolorectaladvancedneoplasiainchinesepopulation
AT dongdong validationoftheasiapacificcolorectalscreeningscoreanditsmodifiedversionsinpredictingcolorectaladvancedneoplasiainchinesepopulation
AT zhuolang validationoftheasiapacificcolorectalscreeningscoreanditsmodifiedversionsinpredictingcolorectaladvancedneoplasiainchinesepopulation
AT loupeian validationoftheasiapacificcolorectalscreeningscoreanditsmodifiedversionsinpredictingcolorectaladvancedneoplasiainchinesepopulation
AT caiting validationoftheasiapacificcolorectalscreeningscoreanditsmodifiedversionsinpredictingcolorectaladvancedneoplasiainchinesepopulation
AT chensiting validationoftheasiapacificcolorectalscreeningscoreanditsmodifiedversionsinpredictingcolorectaladvancedneoplasiainchinesepopulation
AT panjianqiang validationoftheasiapacificcolorectalscreeningscoreanditsmodifiedversionsinpredictingcolorectaladvancedneoplasiainchinesepopulation
AT gaoyihuan validationoftheasiapacificcolorectalscreeningscoreanditsmodifiedversionsinpredictingcolorectaladvancedneoplasiainchinesepopulation
AT luhang validationoftheasiapacificcolorectalscreeningscoreanditsmodifiedversionsinpredictingcolorectaladvancedneoplasiainchinesepopulation
AT mayue validationoftheasiapacificcolorectalscreeningscoreanditsmodifiedversionsinpredictingcolorectaladvancedneoplasiainchinesepopulation
AT dongzongmei validationoftheasiapacificcolorectalscreeningscoreanditsmodifiedversionsinpredictingcolorectaladvancedneoplasiainchinesepopulation
AT luoxiaohu validationoftheasiapacificcolorectalscreeningscoreanditsmodifiedversionsinpredictingcolorectaladvancedneoplasiainchinesepopulation
AT zhaohongying validationoftheasiapacificcolorectalscreeningscoreanditsmodifiedversionsinpredictingcolorectaladvancedneoplasiainchinesepopulation